Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149514 (
bronchitis
)
6,902
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lipid peroxidation (LPO) in the blood plasma and erythrocytes was studied in 99 inhabitants of the southern part of West Siberia suffering from chronic bronchitis, of them 64 with obstructive
bronchitis
. They were sent for treatment to the contrast climatic zone (Yalta, the Crimea), and LPO was examined before the
trip
and after return in the course of a month (three times). LPO activity at a later stage as compared to the initial one was raised in the patients with signs of disadaptation (54 patients). The time course of LPO up to the initial level was over up to the 12th day after return in the patients with moderate symptoms of disadaptation in the warm season and up to the 30th day in the cold period. LPO activity in the patients with pronounced symptoms of disadaptation was more noticeable, the time course of the indicators up to the initial level was more delayed, particularly in erythrocytes and in the cold season. Thus LPO activity in chronic bronchitis in terms of its expression and period depends on patients' adaptogenicity to contrast change of climatic geographic zones after therapy in a sanatorium.
...
PMID:[Lipid peroxidation as an indicator of the adaptive capacity of patients with chronic bronchitis during sanatorium and health resort treatment with a change in climate and geography]. 293 45
The purpose of this study was to assess the incidence of medical illness among members of trekking groups in the Nepal Himalaya. The design was a cohort study using interview and clinical examination by a single physician. The setting was the Manaslu area in the central Nepal Himalaya along a 22-day trekking route with elevations ranging from 487 m to 5100 m. Subjects were 155 members of commercial trekking groups: 102 Nepali porters, 31 Nepali trek staff, and 22 Western trekkers. We found that medical problems occurred in 45% of party members. The porter cohort contained the highest diversity and severity of illness. The relatively larger porter cohort experienced 77% of the medical problems recorded compared with 17% among Western trekkers and 6% among trek staff. The incidence of medical problems was not significantly different in the porter staff (52%) and Western trekkers (55%) and was significantly lower for the trek staff (13%). High-altitude pharyngitis/
bronchitis
was the most common illness in the party (12%) followed by acute mountain sickness (8%) and gastroenteritis (6%). Other conditions included anxiety (3%), cellulitis (3%), scabies (3%), snow blindness (3%), acute alcohol intoxication (2%), conjunctivitis (2%), fever (2%), lacerations (2%), and hemorrhoids (1%). Illness with infectious etiologies comprised 33% of the medical problems. The incidence of altitude illness was not significantly less in the Nepali porter staff than in the Western trekkers. Evacuation was required in 5% of party members, all from the porter group. This study should alert expedition medical providers and
trip
leaders of the need to be observant for and prepared to treat the frequent and diverse medical problems among the porter staff in their party, in addition to the Western members. Medical problems are common in remote mountainous areas, indicating that
trip
physicians should be experienced in primary care.
...
PMID:Medical problems of porters and trekkers in the Nepal Himalaya. 1199 Jan 44